In a previous study, we found that IL-1β released by NSCLC cells activates NF-κB and, thus, suppresses the expression of miR-22-3p (miR-22) in HDMECs co-cultured with NSCLC cells. Here, NFKB1 is linked to non-small cell lung carcinoma.